Bioqube Ventures
Joris De Maeyer is an experienced professional in the life sciences and venture capital sectors, currently serving as Executive in Residence, Investment Director, and Venture Coach at Bioqube Ventures since April 2016. Additionally, Joris holds the position of Board Observer at Anavo Therapeutics BV and is the Founder of Stealth Mode NewCo as of 2023. Since 2013, Joris has been the Managing Director of LIFE of SCI, and previously held multiple roles including Chief Executive Officer and Chief Scientific Officer at Facio Therapies from 2014 to 2022. Earlier career experiences include positions at Shire, Movetis, and Johnson & Johnson, with a foundation in research at KU Leuven and a PhD in Medical Sciences from Ghent University.
Bioqube Ventures
Bioqube Ventures is a specialist life sciences investment firm. We source, finance and develop innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors. Bioqube Ventures was incorporated by Debora Dumont and Nico Vandervelpen in 2015 with the sole aim to invest in groundbreaking and innovative therapeutics. In 2016, Bioqube launched its first investment vehicle on the Janssen campus in Beerse. In 2020, Bioqube launched its second investment vehicle "Bioqube Factory Fund I - BFF I" … An early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients. … A fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … A hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths. BFF I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (“EFSI”) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing.